New Genetic Analysis Finds Clues to Animal Origin of Covid Outbreak
Sort by
Date
Items per page
-
Wegovy users keep weight off for 4 years, large new analysis finds
Patients taking Novo Nordisk’s Wegovy obesity treatment maintained an average of 10% weight loss after four years, potentially boosting the drugmaker’s case to insurers and governments to cover the cost of the effective but expensive drug.NBC News - Top stories -
Wegovy users sustain weight loss for 4 years, new analysis shows
Trial participants also had cardiovascular benefits regardless of weightFinancial Times - Business